Achieve Life Sciences (ACHV) Net Income towards Common Stockholders (QoQ) (2010 - 2018)
Achieve Life Sciences (ACHV) Net Income towards Common Stockholders (QoQ) (2010 - 2018) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2018 |
-12.25% |
| Sep 30, 2018 |
-16.21% |
| Jun 30, 2018 |
7.74% |
| Mar 31, 2018 |
19.20% |
| Dec 31, 2017 |
60.21% |
| Sep 30, 2017 |
-5,562.65% |
| Jun 30, 2017 |
49.54% |
| Mar 31, 2017 |
46.33% |
| Dec 31, 2016 |
-51.36% |
| Dec 31, 2012 |
-743.46% |
| Sep 30, 2012 |
40.45% |
| Jun 30, 2012 |
161.44% |
| Mar 31, 2012 |
65.31% |
| Dec 31, 2011 |
-342.44% |
| Sep 30, 2011 |
-168.45% |
| Jun 30, 2011 |
314.45% |
| Mar 31, 2011 |
-8.75% |
| Dec 31, 2010 |
59.38% |
| Sep 30, 2010 |
-17.93% |
